Merck & Co
Merck & Co

MRK - Merck & Co • Dividends

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
9/15/2026
0,85
Quarterly
6/15/2026
0,85
Quarterly
3/16/2026
0,85
Quarterly
12/15/2025
0,85
Quarterly
9/15/2025
0,81
Quarterly
6/16/2025
0,81
Quarterly
3/17/2025
0,81
Quarterly
12/16/2024
0,81
Quarterly
9/16/2024
0,77
Quarterly
6/17/2024
0,77
Quarterly
3/14/2024
0,77
Quarterly
12/14/2023
0,77
Quarterly
9/14/2023
0,73
Quarterly
6/14/2023
0,73
Quarterly
3/14/2023
0,73
Quarterly
12/14/2022
0,73
Quarterly
1/10

The latest dividend from MRK was $0.85 per share (ex-dividend 9/15/2026). The dividend yield over the last 12 months is 2,3%. Over the last 12 months there were 4 distributions, totalling $3.40 per share.